221 filings
Page 8 of 12
CT ORDER
nki68ha29gjzt
29 Aug 18
Confidential treatment order
12:00am
8-K
mlwgic6kgl9njju2jmn
20 Aug 18
Athenex Appoints Randoll Sze as Chief Financial Officer
12:00am
8-K
4pw3zkkldztqyj
17 Aug 18
Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Compounded Vasopressin Injection inReady-to-Use Premix IV Bags
4:59pm
8-K
6042vvpnqvj0ui
14 Aug 18
Athenex, Inc. Announces Second Quarter 2018 Results and Provides Corporate Update
7:00am
D
it37y4e6idret 0u2
17 Jul 18
$50M in equity / options, sold $50M, 1 investor
4:43pm
8-K
yciq3m9 s3gr
2 Jul 18
Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors
4:06pm
8-K
jtcua8
15 Jun 18
Athenex Announces Appointment to Board of Directors
4:16pm
8-K
ga1pto56bu8a mv6
14 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
au4g40m
14 May 18
Athenex, Inc. Announces First Quarter 2018 Results
8:02am
DEFA14A
y62q391d22 10l54w3z0
30 Apr 18
Additional proxy soliciting materials
7:09am
DEF 14A
w498a5ris38h ygbhw
30 Apr 18
Definitive proxy
7:04am
8-K
u0yu444op
30 Apr 18
Athenex, Inc. Announces Transition of James Zukin from
6:50am
10-K
8fifdop1gn se
26 Mar 18
Annual report
12:00am
8-K
brc9kd9efo
26 Mar 18
Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results
12:00am
8-K
bq6id8tb4wuc
16 Mar 18
Departure of Directors or Certain Officers
12:00am
424B4
hba6vpk
25 Jan 18
Prospectus supplement with pricing info
12:00am
EFFECT
0vt8z6d0
24 Jan 18
Notice of effectiveness
12:00am
CORRESP
q4ls7 sft
22 Jan 18
Correspondence with SEC
12:00am